These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11145432)

  • 21. Functional significance of novel neurotrophin-1/B cell-stimulating factor-3 (cardiotrophin-like cytokine) for human myeloma cell growth and survival.
    Burger R; Bakker F; Guenther A; Baum W; Schmidt-Arras D; Hideshima T; Tai YT; Shringarpure R; Catley L; Senaldi G; Gramatzki M; Anderson KC
    Br J Haematol; 2003 Dec; 123(5):869-78. PubMed ID: 14632778
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation.
    Yamanaka Y; Nakajima K; Fukada T; Hibi M; Hirano T
    EMBO J; 1996 Apr; 15(7):1557-65. PubMed ID: 8612579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IL-6 triggers cell growth via the Ras-dependent mitogen-activated protein kinase cascade.
    Ogata A; Chauhan D; Teoh G; Treon SP; Urashima M; Schlossman RL; Anderson KC
    J Immunol; 1997 Sep; 159(5):2212-21. PubMed ID: 9278309
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis.
    Levy Y; Labaume S; Colombel M; Brouet JC
    Clin Exp Immunol; 1996 Apr; 104(1):167-72. PubMed ID: 8603522
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors.
    Gu ZJ; De Vos J; Rebouissou C; Jourdan M; Zhang XG; Rossi JF; Wijdenes J; Klein B
    Leukemia; 2000 Jan; 14(1):188-97. PubMed ID: 10637495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells.
    Cheung WC; Van Ness B
    Leukemia; 2002 Jun; 16(6):1182-8. PubMed ID: 12040451
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Construction of membrane-anchored interleukin-6 receptor beta subunit mutant and its effect on IL-6 signal transduction].
    Yang Z; Ni C; Shen B; Wang J; Wang Z
    Zhonghua Xue Ye Xue Za Zhi; 2000 Dec; 21(12):632-5. PubMed ID: 11877037
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GP130 cytokines, interferon, survival and proliferation of human myeloma cells.
    Klein B
    Eur Cytokine Netw; 1997 Sep; 8(3):323. PubMed ID: 9346376
    [No Abstract]   [Full Text] [Related]  

  • 29. Multiple myeloma and B cell lymphoma. Investigation of IL-6, IL-6 receptor antagonist (IL-6RA), and GP130 antagonist (GP130A) using various parameters in an in vitro model.
    Kovacs E
    ScientificWorldJournal; 2006 Aug; 6():888-98. PubMed ID: 16892169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. IFN-alpha is a survival factor for human myeloma cells and reduces dexamethasone-induced apoptosis.
    Ferlin-Bezombes M; Jourdan M; Liautard J; Brochier J; Rossi JF; Klein B
    J Immunol; 1998 Sep; 161(6):2692-9. PubMed ID: 9743325
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of the signal transducer gp130 by interleukin-11 and interleukin-6 is mediated by similar molecular interactions.
    Dahmen H; Horsten U; Küster A; Jacques Y; Minvielle S; Kerr IM; Ciliberto G; Paonessa G; Heinrich PC; Müller-Newen G
    Biochem J; 1998 May; 331 ( Pt 3)(Pt 3):695-702. PubMed ID: 9560294
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epitope peptides from interleukin-6 receptor which inhibit the growth of human myeloma cells.
    Halimi H; Eisenstein M; Oh JW; Revel M; Chebath J
    Eur Cytokine Netw; 1995; 6(3):135-43. PubMed ID: 8589270
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interleukin 6 receptor superantagonists are potent inducers of human multiple myeloma cell death.
    Demartis A; Bernassola F; Savino R; Melino G; Ciliberto G
    Cancer Res; 1996 Sep; 56(18):4213-8. PubMed ID: 8797594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transactivation of gp130 in myeloma cells.
    French JD; Walters DK; Jelinek DF
    J Immunol; 2003 Apr; 170(7):3717-23. PubMed ID: 12646637
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction.
    Ogata A; Nishimoto N; Shima Y; Yoshizaki K; Kishimoto T
    Blood; 1994 Nov; 84(9):3040-6. PubMed ID: 7949175
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The myeloma cell antigen syndecan-1 is lost by apoptotic myeloma cells.
    Jourdan M; Ferlin M; Legouffe E; Horvathova M; Liautard J; Rossi JF; Wijdenes J; Brochier J; Klein B
    Br J Haematol; 1998 Mar; 100(4):637-46. PubMed ID: 9531328
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The cytoplasmic tyrosine motifs in full-length glycoprotein 130 have different roles in IL-6 signal transduction.
    Schmitz J; Dahmen H; Grimm C; Gendo C; Müller-Newen G; Heinrich PC; Schaper F
    J Immunol; 2000 Jan; 164(2):848-54. PubMed ID: 10623831
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Establishment and characterization of three myeloma cell lines that demonstrate variable cytokine responses and abilities to produce autocrine interleukin-6.
    Westendorf JJ; Ahmann GJ; Greipp PR; Witzig TE; Lust JA; Jelinek DF
    Leukemia; 1996 May; 10(5):866-76. PubMed ID: 8656685
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Different epitopes are required for gp130 activation by interleukin-6, oncostatin M and leukemia inhibitory factor.
    Timmermann A; Pflanz S; Grötzinger J; Küster A; Kurth I; Pitard V; Heinrich PC; Müller-Newen G
    FEBS Lett; 2000 Feb; 468(2-3):120-4. PubMed ID: 10692570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characterization of soluble gp130 released by melanoma cell lines: A polyvalent antagonist of cytokines from the interleukin 6 family.
    Montero-Julian FA; Brailly H; Sautès C; Joyeux I; Dorval T; Mosseri V; Yasukawa K; Wijdenes J; Adler A; Gorin I; Fridman WH; Tartour E
    Clin Cancer Res; 1997 Aug; 3(8):1443-51. PubMed ID: 9815830
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.